These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2588128)

  • 1. [Treatment procedures in the vasoconstrictive form of hypertension using calcium antagonists in relation to their effect on kidney function].
    Tikhonov VP; Zenchenko DI
    Ter Arkh; 1989; 61(7):108-12. PubMed ID: 2588128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of the delayed-action form of korinfar in arterial hypertension, stenocardia and hypertrophic cardiomyopathy].
    Barats SS; Smolenskaia OG; Klets FKh; Zubareva TV; Zakroeva AG; Kots IaI; Tenchurina LR
    Ter Arkh; 1996; 68(1):39-42. PubMed ID: 8644029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of moderate to severe hypertension and proteinuria by nifedipine retard and perindopril after renal transplantation.
    Grekas D; Dioudis C; Kalevrosoglou I; Papoulidou F; Goutsaridis N; Alivanis P; Tourkantonis A
    Clin Nephrol; 1995 Nov; 44(5):299-302. PubMed ID: 8605709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of calcium entry blockers in hypertensive emergencies.
    Bauer JH; Reams GP
    Circulation; 1987 Jun; 75(6 Pt 2):V174-80. PubMed ID: 3552314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological basis for use of calcium antagonists in hypertension.
    Scriabine A; Kazda S
    Magnesium; 1989; 8(5-6):253-65. PubMed ID: 2693846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Kidney function and the effectiveness of hypotensive therapy of patients with hypertension].
    Tikhonov VP; Bol'shakova RKh
    Ter Arkh; 1986; 58(8):73-6. PubMed ID: 3764766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects.
    Leonetti G; Cuspidi C; Sampieri L; Terzoli L; Zanchetti A
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S319-24. PubMed ID: 6184561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The hemodynamic reactions of hypertension patients taking the calcium antagonists finoptin and korinfar].
    Goloshchapov OA; Goldabin VI; Geller AL; Mashin AA
    Ter Arkh; 1990; 62(10):149-52. PubMed ID: 2084881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, beta-receptor blockers, and their combination in hypertensive patients.
    Franz IW; Wiewel D
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1037-42. PubMed ID: 6085363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium influx mediated vasoconstriction: studies in patients with mild and moderate essential hypertension.
    Hulthén UL; Bolli P; Bühler FR
    J Hypertens Suppl; 1983 Dec; 1(2):105-8. PubMed ID: 6599487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hemodynamics of calcium-channel antagonists in hypertension: vascular and myocardial responses.
    Cody RJ
    Circulation; 1987 Jan; 75(1 Pt 2):I175-9. PubMed ID: 3791618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal adaptive mechanisms in aged and hypertensive humans: possible effects of treatment.
    Di Serio C; Cristofari C; Torrini M; Cantini C; Lambertucci L; Castellani S; Masotti G; Ungar A
    Med Sci Monit; 2001; 7(6):1203-11. PubMed ID: 11687731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal hemodynamics in hypertensive renal allograft recipients: effects of calcium antagonists and ACE inhibitors.
    Grekas D; Dioudis C; Kalevrosoglou I; Alivanis P; Derveniotis V; Tourkantonis A
    Kidney Int Suppl; 1996 Jun; 55():S97-100. PubMed ID: 8743523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium antagonists in the treatment of nephrogenic hypertension].
    Tareeva IE; Kutyrina IM; Galstian GM; Rogov VA
    Klin Med (Mosk); 1990 Aug; 68(8):52-6. PubMed ID: 2084371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calcium antagonists: a potent vasodilatory principle and alternative basic antihypertensive therapy].
    Bolli P; Erne P; Bühler FR
    Schweiz Med Wochenschr; 1983 Nov; 113(46):1733-5. PubMed ID: 6658418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verapamil compared with nifedipine in the treatment of essential hypertension.
    Midtbø K; Hals O; van der Meer J
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S363-8. PubMed ID: 6184569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.